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Purpose: The aim of this study is to evaluate the effect of dexmedetomidine on 
corrected QT (QTc) and Tp-e intervals in patients undergoing spinal anesthesia. 
Materials and Methods: We studied 50 patients who were scheduled to undergo 
spinal anesthesia before orthopedic surgeries. Patients were allocated to receive ei-
ther an infusion of dexmedetomidine or normal saline after spinal anesthesia. Re-
sults: QTc intervals were significantly prolonged after spinal anesthesia, and the 
prolonged QTc interval returned to baseline values 10 minutes after either normal 
saline or dexmedetomidine administration in both groups. The QTc interval values 
after dexmedetomidine administration were significantly shorter compared to the 
QTc interval values just before dexmedetomidine administration. Conclusion: 
Dexmedetomidine could promote the return of a prolonged QTc interval induced 
by spinal anesthesia and might be helpful in patients who have a prolonged QTc 
interval.
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INTRODUCTION
Sedation provides a comfortable and relaxed condition for patients undergoing re-
gional anesthesia and reduces the anxiety of surgery by preventing unpleasant 
memories. To produce these effects, dexmedetomidine, which has sedative, anal-
gesic, and sympatholytic effects, has been widely used. There is some concern that 
dexmedetomidine might cause circulatory complications, including hypertension, 
hypotension, and bradycardia.1 However, there are few reports about its effect on 
cardiac electrophysiology, and the findings from these reports are controversial.2-4 
The corrected QT (QTc) interval prolongation is frequently caused by drugs which 
block the rapid and slow components of the potassium-delayed rectifying cur-
rent.5,6 The interaction of dexmedetomidine with alpha-2-adrenoreceptors results 
in an alteration in ion channel conductance and decreased neuronal activation,7,8 
which can alter cardiac electrophysiology. 
The aim of this study was to examine the effect of dexmedetomidine on QTc in-
terval and the interval from the peak of the T wave to the end of the T wave (Tp-e) 
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formed at the level of L3-4 or L4-5 interspace in the lateral 
decubitus position, using a 22G or 25G spinal needle. After 
identification of the subarachnoid space (outflow of the ce-
rebrospinal fluid), 8 mg to 13 mg 0.5% hyperbaric bupiva-
caine solution (Marcaine Spinal 0.5% Heavy; AstraZeneca, 
Södertälje, Sweden) was administered. Immediately after 
drug injection, the patient was placed in a supine position. 
We recorded the upper sensory block level at 15 minutes 
after bupivacaine injection using a thermal test. 
Participants were split into two groups: Group C (control, 
n=25) and Group D (dexmedetomidine, n=25). Patients 
who did not want to sleep were allocated to Group C, and 
those who wanted to sleep to Group D. Immediately after 
assessment of the sensory block level, 0.6 µg/kg of dexme-
detomidine was administered intravenously over a 10 min 
period, followed by a continuous infusion at a dose of 0.4 
µg/kg/hr in Group D. In Group C, volume-matched normal 
saline infusion was administered as a placebo. The ECG 
was continuously recorded during the entire study period. A 
decrease in mean arterial pressure (MAP) greater than 20% 
after administration of spinal anesthesia was defined as hy-
potension. Hypotension was initially treated with fluid re-
suscitation and, if the MAP did not respond, 4-8 mg IV 
ephedrine was administered. Bradycardia (<45 beats per 
minute, bpm) was treated with 0.25-0.5 mg atropine. Time 
points for the ECG analysis were: baseline, 5, 10, and 15 
minutes after spinal anesthesia and 10, 40, and 70 minutes 
after infusion of dexmedetomidine or normal saline. The 
HR and MAP were recorded at the same time as the ECG 
measurements. The infusion of dexmedetomidine or nor-
mal saline continued until the surgery was complete. 
Statistical analyses were performed using SPSS version 
20 (SPSS Inc., Chicago, IL, USA) for Windows. All values 
were expressed as mean (SD). Sample size was calculated 
with 80% power (p=0.05, β=0.2) to detect a mean differ-
ence of 20 ms in the QTc interval between baseline and af-
ter spinal block and a standard deviation of 23 ms with a 
paired t-test. Using this formula, we required a minimum 
sample size of 21 patients per group. Demographic data 
were analyzed using the chi-squared test or Student’s t-test, 
as appropriate. Student’s t-tests were used to compare the 
baseline values of the QTc, Tp-e, HR, and MAP between 
the two groups. The differences within groups were ana-
lyzed using repeated measures ANOVA, and post hoc Bon-
ferroni correction was applied where multiple comparisons 
were made. A value of p<0.05 was considered statistically 
significant.
in patients undergoing spinal anesthesia for elective ortho-
pedic surgeries. 
MATERIALS AND METHODS
　　　
After obtaining approval from the Yonsei University Col-
lege of Medicine Institutional Review Board and written 
informed consent from all participants, 50 patients (age 20 
to 60 years, American Society of Anesthesiologists physical 
status I) who were scheduled for orthopedic surgery and 
spinal anesthesia were enrolled. We excluded patients with 
a preoperative QTc interval value >440 ms, preoperative 
electrocardiogram (ECG) abnormalities of conductivity or 
arrhythmias, a history of heart disease or circulatory insuffi-
ciency, any preoperative electrolyte abnormalities or medi-
cations known to prolong the QTc interval, of if they re-
quired general anesthesia due to incomplete block or high 
level of spinal anesthesia. 
All study data were collected in the morning (8:30 AM to 
11:30 AM) to avoid the effects of day-night changes on the 
QTc interval. No premedication was administered. After 
patients were taken into the operating room, pulse oximetry 
and non-invasive blood pressure monitoring were estab-
lished. Data from a continuous ECG via lead II were col-
lected using LabChart® software (Version 6: AD Instru-
ments, Colorado Springs, CO, USA) and a data acquisition 
system (PowerLab®; AD Instruments) by a single author. 
For each patient, the data were saved in a separate file and 
coded using the patient enrollment number. The QT inter-
val from the onset of the QRS complex to the end of the T 
wave and Tp-e interval from the peak of the T wave to the 
end of the T wave were measured automatically. If the au-
tomatic measurement did not correctly detect the earliest 
onset of the QRS complex or the end of the T wave, the QT 
and Tp-e intervals were measured manually, using the cur-
sor from the earliest onset of the QRS complex to the latest 
end of the T wave, where its terminal limb joined the base-
line.9 The QT interval and Tp-e interval were measured by 
a different author who was blinded to the group allocation 
of each patient. Each recorded measurement of QT and 
Tp-e interval was averaged from four successive beats. 
Heart rate (HR) correction was performed according to the 
Fridericia formula: QTc=QT3√(R-R interval).10
 After obtaining the baseline ECG, an intravenous pre-
load of 300 mL to 400 mL 0.9% normal saline or Hart-
mann’s solution was infused. Spinal anesthesia was per-
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dexmedetomidine administration were significantly short-
ened when compared to the QTc interval value at 15 minutes 
after spinal anesthesia (just before dexmedetomidine admin-
istration), but those QTc values were not different from the 
baseline value in Group D. No significant changes in the 
Tp-e interval from baseline were observed in either group at 
any measurement time (Table 2). There was no significant 
change of MAP in either group among patients, who did not 
require administration of ephedrine (Fig. 1). The HR did not 
change during the study period in Group C, but the HR at 10, 
40, 70 minutes after administration of dexmedetomidine was 
significantly decreased compared to the baseline value 
(p<0.01, 0.001, and 0.001, respectively) and the value at 15 
minutes after spinal anesthesia (p<0.05, 0.01, and 0.01, re-
spectively) in Group D (Fig. 2). We did not observe any 
complications, such as significant changes in MAP or ar-
rhythmias, in either group in the post-anesthetic care unit. 
DISCUSSION
We observed that spinal anesthesia provoked QTc interval 
prolongation in patients without cardiovascular disorders, 
and that the prolonged QTc interval returned to baseline 
RESULTS
 
Fifty patients were recruited to the study (27 male, 23 fe-
male). One patient in Group C and two patients in Group D 
were excluded from the final analysis to avoid the confound-
ing effects of other agents because 0.25-0.5 mg atropine 
was administered due to bradycardia (<45 bpm). Patient 
characteristics in Group C and D are shown in Table 1, and 
were similar for the two groups. 
All patients had normal baseline ranges of HR, MAP, and 
QTc intervals at rest, and there were no statistically signifi-
cant differences in baseline HR, MAP, QTc, and Tp-e value 
between the two groups. In Group C, the QTc interval was 
significantly prolonged at 10 and 15 minutes after induction 
of spinal anesthesia compared to baseline value (p<0.05). 
There was no difference in QTc interval at 10, 40, and 70 
minutes after administration of placebo (normal saline) com-
pared to either the baseline QTc value or the QTc value at 15 
minutes after spinal anesthesia. In Group D, the QTc interval 
was significantly prolonged at 5, 10, and 15 minutes (p<0.05, 
0.01 and 0.05, respectively) after spinal anesthesia compared 
to the baseline value. The values of QTc interval at 10, 40, 
and 70 minutes (p<0.001, 0.05 and 0.001, respectively) after 
Table 1. Patient Demographic Data 
Group C (n=25) Group D (n=25)
Sex (M:F) 13/12 14/11
Age (yrs)     39.1 (17.5)     40.4 (13.7)
Height (cm) 166.9 (9.8) 168.2 (9.5)
Weight (kg)     68.7 (14.7)   66.3 (9.5)
Sensory block level T7 [T4-T10 (T4-T12)] T6 [T4-T9 (T4-T12)]
Bupivacaine dose (mg)   10.9 (2.9)   11.1 (1.2)
Group C=control, Group D=dexmedetomidine. Values are number of patients, mean (SD), or median [interquartile range (range)].
Table 2. Electrocardiographic Parameters of Patients Under Spinal Anesthesia 
Group C (n=24) Group D (n=23)
QTc (ms) Tp-e (ms) QTc (ms) Tp-e (ms)
Baseline value 351.3 (20.0) 49.0 (13.9) 353.8 (17.3) 49.4 (13.4)
Time after spinal anesthesia 
    5 mins 360.5 (23.8) 52.2 (19.1) 366.6 (16.0)* 51.3 (11.6)
    10 mins   362.1 (22.2)* 49.0 (13.8) 367.1 (15.2)† 52.3 (10.9)
    15 mins   361.9 (23.5)* 46.5 (11.1) 363.6 (17.0)* 51.0 (8.9)
Time after drug administration 
    10 mins 357.8 (21.2) 49.1 (13.7) 350.4 (18.1)§ 49.2 (7.0)
    40 mins 357.6 (17.9) 48.7 (11.7) 353.5 (18.8)‡ 49.6 (10.4)
    70 mins 354.8 (20.8) 49.1 (11.5) 350.8 (13.1)§ 48.4 (9.0)
Group C=control, Group D=dexmedetomidine. Values are mean (SD).
*p<0.05 and †p<0.01 compared with the baseline value. 
‡p<0.05 and §p<0.001 compared with the value at 15 min after spinal anesthesia.
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potential influence of premedication agents on cardiac elec-
trophysiology. Therefore, the absence of premedication 
might lead to the activation of the sympathetic nervous sys-
tem. Another possible reason for QTc interval prolongation 
during spinal anesthesia is that it is a compensatory mecha-
nism of thoracic sympathetic stimulation by cardiac accel-
erating nerve fibers (T1-T4), which were preserved after 
spinal blockade.18,19 The QTc interval was maximally pro-
longed at 10 min after spinal blockade in both groups, and 
the prolonged average value of QTc interval value was about 
11 ms and 14 ms in Group C and Group D, respectively. 
The degree of the QTc interval may not be clinically harm-
ful to healthy patients because none of the enrolled patients 
showed a QTc interval over 440 ms, and the extent of QTc 
interval prolongation was less than 20 ms, which was re-
garded as a prolongation of the QTc interval.5,6 Additionally, 
the Tp-e interval, which is considered to be a more reliable 
predictor of risk for torsades de pointes, was not modified at 
values after 15 min following spinal anesthesia. Adminis-
tration of dexmedetomidine promoted the return of the pro-
longed QTc interval that was induced by spinal blockade 
and did not modify the Tp-e interval. 
Although there have been few reports about the effect of 
spinal anesthesia on cardiac electrophysiology, Owczuk, et 
al.11 reported that spinal anesthesia induced significant QTc 
interval prolongation in healthy patients, which is in accor-
dance with our results. Although the mechanism is still un-
clear, prolongation of the QTc interval may be attributed to 
sympathetic stimulation rather than the drug itself for re-
gional anesthesia.12,13 It is well recognized that sympathetic 
activation provokes changes in cardiac repolarization14 and 
repolarization abnormalities.15 Therefore, the agents includ-
ing opioids or β-adrenergic blockers, which can reduce the 
sympathetic stimulation, are considered for patients who are 
vulnerable to QTc interval prolongation.16,17 Our patients 
were not premedicated before spinal anesthesia for fear of a 
Fig. 1. Mean arterial pressure before anesthesia (baseline) and after spinal anesthesia (SA) and after administration of drug (normal saline in Group C and 
dexmedetomidine in Group D, respectively). Error bars are SD. 
Fig. 2. Heart rate before anesthesia (baseline) and after spinal anesthesia (SA) and after administration of drug (normal saline in Group C and dexmedetomi-
dine in Group D, respectively). *p<0.01 and †p<0.001 compared with the baseline value, ‡p<0.05 and §p<0.01 compared with the SA+15 min value. Errors bar 
are SD.
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ceptor suppresses its own adrenal release from the terminal 
reticulum to the effecter, including the brain system, vascula-
ture, and the heart, achieving sedation, analgesia, decreased 
blood pressure and bradycardia.3 Alpha-2-adrenoreceptor 
agonist modifies the cardiac autonomic state not only by 
suppressing cardiac noradrenaline release, but also by acti-
vating vagal acetylcholine release.24,25 Therefore dexme-
detomidine is probably preferable for vulnerable patients 
with a prolonged QTc interval, especially when accelera-
tion of the sympathetic nervous system is anticipated in the 
operating room. 
A limitation of our study was that the effects of spinal an-
esthesia on myocardial repolarization could not be separat-
ed from the effects of dexmedetomidine. However, the use 
of dexmedetomidine may be desirable for sedation during 
spinal anesthesia in patients at risk of long QT syndrome if 
bradycardia can be properly managed. When the HR is 
slow, diminished accumulation of slowly-activating delayed 
rectifier potassium currents prolongs the duration of the ac-
tion potential.2,26 Therefore, a decreased HR may enhance 
cardiac susceptibility to torsades de pointes in patients with 
prolonged QT interval. Although dexmedetomidine has 
complex and counteracting cardiovascular effects, adverse 
effects such as bradycardia and hypotension are generally 
easily managed. Another limitation of this study is non-ran-
domization in allocating patients. Randomization was not 
possible because this study was not done in volunteers and 
sedation was provided for the patients only who requested 
it before anesthesia. Hence, the baseline activity of sympa-
thetic nervous system might be different between two groups 
since it was expected that the patients who wanted sleep 
would have a tendency to have more anxiety and higher 
sympathetic activity in comparison to the patients who did 
not want to sleep. Measurement of heart rate variability or 
plasma catecholamine would be useful for the assessment 
of baseline activity of sympathetic nervous system. Howev-
er, we could indirectly assume that the sympathetic activi-
ties of two groups were similar since the baseline HR, MAP, 
and QTc intervals were comparable.
In conclusion, spinal anesthesia prolonged the QTc interval 
in healthy patients, but it did not increase the Tp-e interval, 
indicating low or no risk of torsades de pointes. Dexmedeto-
midine could promote the return to baseline of prolonged 
QTc intervals induced by spinal anesthesia. This suggests 
that dexmedetomidine could be useful for patients with pro-
longation of the QTc interval who are susceptible to the de-
velopment of arrhythmia. 
any time after spinal anesthesia compared to baseline val-
ues in either group. The Tp-e interval is a surface ECG 
marker of transmural dispersion of repolarization across the 
myocardial wall, and its exaggeration increases the risk of 
torsades de pointes.20 Our findings support the rationale that 
spinal anesthesia is safe despite a prolonged QTc interval in 
clinical fields. 
Dexmedetomidine increased the dysrhythmogenic thresh-
old of epinephrine during halothane anesthesia in canines2 
and showed an inhibitory effect on ventricular tachyar-
rhythmia in a rabbit model of acquired long QT syndrome.3 
On the contrary, Hammer, et al.4 showed that dexmedeto-
midine significantly prolonged QTc intervals in pediatric 
patients, which contrasts with our results. It is unclear why 
previous results are inconsistent with our findings, but in 
the latter study, concurrent administration of drugs, such as 
propofol and ketamine, and the different disease statuses of 
patients with cardiac conduction abnormalities might com-
plicate the interpretation of the pure effect of dexmedetomi-
dine on QTc. Moreover, the administered drug doses may 
have some influence on the degree of QTc interval prolon-
gation.21,22 Our administered dose (0.6 μg/kg over 10 min-
utes followed by 0.4 μg/kg/hr) was lower than the doses re-
ported by Hammer, et al.4 (1.0 μg/kg over 10 minutes 
followed by 0.7 μg/kg each hour). However, our doses may 
be more clinically applicable during spinal anesthesia be-
cause large doses of dexmedetomidine lead to severe bra-
dycardia that require intervention and, hence, raise safety 
concerns.23 Further study of a dose-response relationship 
between dexmedetomidine and QTc interval are needed in 
the future. 
The prolongation of the QTc interval persisted for 15 
minutes after spinal blockade, and then the prolonged QTc 
interval returned to the baseline value in both groups. Infu-
sion of dexmedetomidine significantly shortened the QTc 
interval compared to the QTc interval at just before admin-
istration of dexmedetomidine. Our findings suggest that 
dexmedetomidine could accelerate the normalization of a 
prolonged QTc interval that was induced by spinal anesthe-
sia or might shorten the value of the baseline QTc interval 
in cases where patients did not have a central blockade. It is 
not easy to infer the mechanism by which dexmedetomidine 
shortens the spinal anesthesia-induced prolonged QTc inter-
val, but it is probably associated with decreasing sympathet-
ic activity. Alpha-2-adrenoreceptor is distributed throughout 
the brain stem, peripheral vasculature, and presympathetic 
nervous terminal as an auto-suppressive receptor. The re-
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